A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Tranylcypromine-[d5] Hydrochloride | Tranylcypromine-[d5] Hydrochloride is the labelled analogue of Tranylcypromine, which has been found to be a monoamine oxidase inhibitor and could be used as an anti-depressant agent. Synonyms: Tranylcypromine D5 Hydrochloride; trans 2-(Phenyl-d5)-cyclopropylamine Hydrochloride. Grade: 95% by HPLC; 98% atom D. CAS No. 107077-98-5. Molecular formula: C9H7D5ClN. Mole weight: 174.68. |  |
| Tranylcypromine hemisulfate | Tranylcypromine (SKF 385) hemisulfate is an irreversible, nonselective monoamine oxidase (MAO) inhibitor used in the treatment of depression. Tranylcypromine hemisulfate is also a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis. Tranylcypromine has antidepressant effects[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SKF 385 hemisulfate. CAS No. 13492-01-8. Pack Sizes: 10 mM * 1 mL in DMSO; 100 mg. Product ID: HY-B1496. |  |
| Tranylcypromine Hemisulfate (Trans (±) -2-Phenyl cyclopropanamine, Hemisulfate; SKF trans-355; 2-PCPA) | An inhibitor of monoamine oxidase (MAO) and prostacyclin synthase. Potently suppresses the enzymatic activity of Lysine-Specific Demethylase 1 (LSD1) (IC50 <2uM for BHC110/LSD1). When combined with GSK-3 Inhibitor CHIR99021, causes reprogramming of human primary keratinocyte transduced with two factors, Oct4 and Klf4. Group: Biochemicals. Alternative Names: Trans (±) -2-Phenyl cyclopropanamine, Hemisulfate; SKF trans-355; 2-PCPA. Grades: Highly Purified. CAS No. 13492-01-8. Pack Sizes: 25mg. US Biological Life Sciences. |  Worldwide |
| Tranylcypromine hydrochloride | Tranylcypromine hydrochloride (SKF 385 hydrochloride) is an irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110) and monoamine oxidase (MAO). Tranylcypromine hydrochloride inhibits LSD1, MAO A and MAO B with IC50s of 20.7, 2.3 and 0.95 μM, respectively. Tranylcypromine hydrochloride can be used for the research of depression[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SKF 385 hydrochloride. CAS No. 1986-47-6. Pack Sizes: 10 mM * 1 mL in DMSO; 100 mg; 250 mg; 500 mg. Product ID: HY-17447A. | |
| Tranylcypromine hydrochloride | Tranylcypromine hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 1986-47-6. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Tranylcypromine Related Compound A | Tranylcypromine Related Compound A. Uses: For analytical and research use. CAS No. 54779-58-7. Mole weight: 169.65. Catalog: AP54779587. |  |
| Tranylcypromine Related Compound B | Tranylcypromine Related Compound B. Uses: For analytical and research use. CAS No. 17480-08-9. Mole weight: 169.65. Catalog: AP17480089. | |
| TRAP-1 | TRAP-1 (XJZ-06-462) is a non-covalent regulated induced proximity targeting chimera (RIPTAC) with JQ-1 carboxylic acid (HY-78695) as its target protein ligand. TRAP-1 forms a ternary complex with p53Y220C and BRD4, potently activates p53 transcription, and inhibits the growth and proliferation of tumor cells. TRAP-1 upregulates p21 and other p53 target genes in pancreatic cell lines carrying p53Y220C, and induces cellular senescence and apoptosis. TRAP-1 can be used in cancer research involving p53Y220C-carrying tumors[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: XJZ-06-462. CAS No. 3109600-48-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-169369. | |
| Trap 101 | Trap 101. Group: Biochemicals. Grades: Purified. CAS No. 1216621-00-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Trap-101 hydrochloride | Trap-101 hydrochloride. Alternative Names: 873567-76-1, Trap101-HCl, Trap-101 hydrochloride, Trap 101, AKOS016004853, AK102414, KB-81243, BCP0726000201, 1-(1-(Cyclooctylmethyl)-5-(hydroxymethyl)-1,2,3,6-tetrahydropyridin-4-yl)-3-ethyl-1H-benzo[d]imidazol-2(3H)-one hydrochloride, 1-[1-(CYCLOOCTYLMETHYL)-1,2,3,6-TETRAHYDRO-5-(HYDROXYMETHYL)-4-PYRIDINYL]-3-ETHYL-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE HYDROCHLORIDE, 1-[1-(cyclooctylmethyl)-1,2,3,6-tetrahydro-5-(hydroxymethyl)-4-pyridinyl]-3-ethyl-1,3-dihydro-2Hbenzimidazol-2-one hydrochloride, 1216621-00-9. CAS No. 1216621-00-9. Purity: 96%. Product ID: ACM1216621009. Molecular formula: C24H36ClN3O2. Mole weight: 434.01. IUPAC Name: 1-[1-(cyclooctylmethyl)-5-(hydroxymethyl)-3,6-dihydro-2H-pyridin-4-yl]-3-ethylbenzimidazol-2-one;hydrochloride. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| TRAP-14 | TRAP-14 is a synthetic thrombin receptor agonist peptide and causes platelet aggregation (EC50 = 4 μM) and secretion. Synonyms: PAR-1 (1-14) (human); H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH; L-seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagyl-L-prolyl-L-asparagyl-L-alpha-aspartyl-L-lysyl-L-tyrosyl-L-alpha-glutamyl-L-prolyl-L-phenylalanine. Grade: ≥95% by HPLC. CAS No. 137339-65-2. Molecular formula: C81H118N20O23. Mole weight: 1739.92. | |
| TRAP1-IN-1 | TRAP1-IN-1 (compound 35) is a potent and selective inhibitor of TRAP1, a mitochondrial isoform of Hsp90. TRAP1-IN-1 has >250-fold TRAP1 selectivity over Grp94, and disrupts TRAP1 tetramer stability, induces TRAP1 client protein degradation. TRAP1-IN-1 also inhibits mitochondrial complex I of oxidative phosphorylation OXPHOS, disrupts the mitochondrial membrane potential, and enhances glycolysis metabolism[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3031102-94-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-155063. | |
| TRAP-5 | TRAP-5 is a thrombin receptor activator. Thrombin receptor is a G protein-coupled receptor involved in the regulation of thrombotic response. Synonyms: Thrombin Receptor Activator for Peptide 5 (TRAP-5); SFLLR; L-seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginine. Grade: >98%. CAS No. 141685-53-2. Molecular formula: C30H50N8O7. Mole weight: 634.77. | |
| TRAP-5 amide | TRAP-5 amide is an agonist of thrombin receptor. Synonyms: SFLLRamide; H-SFLLR-NH2; L-seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-argininamide; (S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-3-phenylpropanamido)-N-((S)-1-((S)-1-amino-5-guanidino-1-oxopentan-2-ylamino)-4-methyl-1-oxopentan-2-yl)-4-methylpentanamide. Grade: 95%. CAS No. 141923-41-3. Molecular formula: C30H51N9O6. Mole weight: 633.78. | |
| TRAP-6 | TRAP-6, a peptide compound, has been found to be a PAR1 agonist and could also influence the phosphorylation of rapid phosphodiesterase 3A in the positive way. Uses: Trap-6 has been found to be a par1 agonist and could also influence the phosphorylation of rapid phosphodiesterase 3a in the positive way. Synonyms: TRAP-6; TRAP 6; TRAP6; Thrombin Receptor Activator Peptide 6; SFLLRN; SFLLRN-OH; CHEMBL78392. Grade: 98%. CAS No. 141136-83-6. Molecular formula: C34H56N10O9. Mole weight: 748.87. | |
| TRAP-6 | TRAP-6. Group: Biochemicals. Grades: Purified. CAS No. 141136-83-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| TRAP-6 | TRAP-6 (PAR-1 agonist peptide), a peptide fragment, is a selective protease activating receptor 1 (PAR1) agonist. TRAP-6 activates human platelets via the thrombin receptor. TRAP-6 shows no activity at PAR4[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PAR-1 agonist peptide; Thrombin Receptor Activator Peptide 6. CAS No. 141136-83-6. Pack Sizes: 10 mM * 1 mL in Water; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P0078. | |
| TRAP-6 (2-6) | PAR peptides (TRAP peptides and thrombin receptor-like peptides) activate the proteinase-activated receptors PAR-1 to PAR-4. Synonyms: THROMBIN RECEPTOR AGONIST; THROMBIN RECEPTOR (43-47), HUMAN; PHE-LEU-LEU-ARG-ASN; TR (43-47), HUMAN; H-PHE-LEU-LEU-ARG-ASN-OH; FLLRN; phenylalanyl-leucyl-leucyl-arginyl-asparagine; TRAP-6 (2-6). CAS No. 141136-84-7. Molecular formula: C31H51 N9 O7. Mole weight: 661.79. | |
| TRAP-6 amide | TRAP-6 amide is a peptide agonist of the PAR-1 thrombin receptor. Synonyms: SFLLRN-NH2; TRAP6; Ser-Phe-Leu-Leu-Arg-Asn-NH2. CAS No. 141923-40-2. Molecular formula: C34H57N11O8. Mole weight: 747.89. | |
| TRAP-7 | TRAP-7. Synonyms: Thrombin receptor peptide sfllrnp; H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH; L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparaginyl-L-proline; Thrombin receptor activating peptide(1-7)[human]. CAS No. 145229-76-1. Molecular formula: C39H63N11O10. Mole weight: 845.99. | |
| Traseolide | Traseolide. CAS No. 68140-48-7. VIGON Item # 503251. Categories: Speciality Ingrdients Suppliers, Fragrances, musk methyl ketone, Perfumers. |  America & Internationally |
| Trastuzumab | Trastuzumab. CAS No. 180288-69-1. Purity: 96%. Product ID: ACM180288691. Molecular formula: ClH. Mole weight: 36.46094;g/mol. IUPAC Name: chlorane. Canonical SMILES: Cl. ECNumber: 231-595-7. Alfa Chemistry - ISO 9001:32057 Certified. | |
| Trastuzumab | Trastuzumab Inhibitor. Uses: Scientific use. Product Category: T9912. CAS No. 180288-69-1. |  |
| Trastuzumab | Trastuzumab is a humanized IgG1 monoclonal antibody that selectively binds to HER2 with high affinity. Trastuzumab can be used for the research of HER2-positive metastatic breast cancer and gastric cancer[1][2][3]. (Note: The product specifications below only indicate the effective content of Trastuzumab. The component ratio of this product is Trastuzumab : excipients = 1:0.6-1:0.9.). Uses: Scientific research. Category: Signaling pathways. Alternative Names: Anti-Human HER2, Humanized Antibody. CAS No. 180288-69-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P9907. | |
| Trastuzumab (anti-HER2) | Trastuzumab (anti-HER2) is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab (anti-HER2) has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Anti-Human HER2, Humanized Antibody (anti-HER2). CAS No. 180288-69-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P9907A. | |
| Trastuzumab (anti-HER2) | Trastuzumab (anti-human HER2) is a humanized, recombinant monoclonal antibody that binds to the extracellular domain of HER2, MW:145.53 KD. Group: Antibodies. CAS No. 180288-69-1. Pack Sizes: 5mg. Product ID: A2007. Storage Conditions: Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |  United States; Europe |
| Trastuzumab deruxtecan | Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer. Category: Active pharmaceutical ingredients. CAS No. 1826843-81-5. Product ID: API1826843815. Mole weight: 145 kDa (average). |  |
| Trastuzumab deruxtecan | Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: T-DXd; DS-8201; DS-8201a. CAS No. 1826843-81-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-138298A. | |
| Trastuzumab deruxtecan (DS-8201a, T-DXd) | Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. Trastuzumab deruxtecan has a molecular weight of 153KDa. Alternative Names: DS-8201. CAS No. 1826843-81-5. Pack Sizes: 1mg. Product ID: D4001. Formula: 7.8. Storage Conditions: Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. | United States; Europe |
| Trastuzumab deruxtecan (solution) | Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: T-DXd (solution); DS-8201 (solution); DS-8201a (solution). CAS No. 1826843-81-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-138298. | |
| Trastuzumab duocarmazine | Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: (vic)-Trastuzumab duocarmazine. CAS No. 1642152-40-6. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P99547. | |
| Trastuzumab emtansine | Trastuzumab emtansine is an antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab conjugated to the maytansinoid DM1 via a nonreducible thioether linkage (MCC) with potential antineoplastic activity. The trastuzumab moiety of this ADC binds to HER2 on tumor cell surface surfaces. Upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that overexpress HER2. Linkage of antibody and drug through a nonreducible linker has been reported to contribute to the improved efficacy and reduced toxicity of this ADC compared to similar ADCs constructed with reducible linkers. Grade: 95%. CAS No. 1018448-65-1. Molecular formula: C6448H9948N1720O2012S44·(C47H62ClN4O13S)n. | |
| Trastuzumab emtansine | Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (HY-19792). Trastuzumab emtansine can be used for the research of advanced breast cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ado-Trastuzumab emtansine; PRO132365; T-DM 1. CAS No. 1018448-65-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P9921. | |
| Trastuzumab emtansine (solution) | Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine), and the drug-linker conjugate for ADC is SMCC-DM1 (HY-101070). Trastuzumab emtansine can be used for the research of advanced breast cancer[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ado-Trastuzumab emtansine (solution); PRO132365 (solution); T-DM 1 (solution). CAS No. 1018448-65-1. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P9921A. | |
| Trastuzumab Emtansine?T-DM1? | Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.This product is supplied as 10mg/ml PBS solution. Alternative Names: Ado-Trastuzumab emtansine. CAS No. 1018448-65-1. Pack Sizes: 1mg. Product ID: D4003. Formula: 3.6. Storage Conditions: Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. | United States; Europe |
| Trastuzumab impurity 1 | Trastuzumab impurity 1. Uses: For analytical and research use. CAS No. 130878-68-1. Molecular formula: C24H24N2O6. Mole weight: 436.46. Catalog: APB130878681. | |
| Trastuzumab impurity 2 | Trastuzumab impurity 2. Uses: For analytical and research use. CAS No. 159858-22-7. Molecular formula: C33H39N5O6. Mole weight: 601.7. Catalog: APB159858227. | |
| Trastuzumab impurity 3 | Trastuzumab impurity 3. Uses: For analytical and research use. CAS No. 34321-81-8. Molecular formula: C8H11NO4. Mole weight: 185.18. Catalog: APB34321818. | |
| Traumatic acid | Traumatic acid. Alternative Names: trans-2-Dodecene-1,12-dioic acid. CAS No. 6402-36-4. Purity: >90.0%. Product ID: FFC-AR-6402364. Molecular formula: C12H20O4. Mole weight: 228.28. IUPAC Name: (E)-dodec-2-enedioic acid. Alfa Chemistry - ISO 9001:32057 Certified. | |
| Traumatic Acid | Traumatic Acid, is the product of a biosynthetic pathway from a physiological role of alpha-ketol fatty acids in plant lipid hydroperoxide lyase metabolism. This compound is also used in would healing as it stimulates cell division to form a protective callus around the wound site. Group: Biochemicals. Grades: Highly Purified. CAS No. 6402-36-4. Pack Sizes: 100mg, 500mg. Molecular Formula: C12H20O4, Molecular Weight: 228.28. US Biological Life Sciences. | Worldwide |
| Travaprost | Travaprost. Group: Biochemicals. Grades: Purified. CAS No. 157283-68-6. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Travoprost | Selective FP prostaglandin receptor agonist. Isopropyl ester of (+)-fluprostenol. Antiglaucoma. Used to treat glaucoma. Group: Biochemicals. Alternative Names: (5Z) -7-[ (1R, 2R, 3R, 5S) -3, 5-Dihydroxy-2-[ (1E, 3R) -3-hydroxy-4-[3- (trifluoromethyl) phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester; AL 6221; Travaprost; Travatan. Grades: Highly Purified. CAS No. 157283-68-6. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C??H??F?O?, Molecular Weight: 500.55. US Biological Life Sciences. | Worldwide |
| Travoprost | Travoprost (Fluprostenol isopropyl ester), an isopropyl ester proagent, is a high affinity, selective FP prostaglandin full receptor agonist. Travoprost has the ocular hypotensive efficacy and has the potential for glaucoma and ocular hypertension[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Fluprostenol isopropyl ester; AL6221; Flu-Ipr. CAS No. 157283-68-6. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-B0584. | |
| Travoprost Related Compound A | Travoprost Related Compound A. Uses: For analytical and research use. CAS No. 54276-17-4. Mole weight: 458.47. Catalog: AP54276174. | |
| Traxillaside | Traxillaside is purified from the barks of Torreya nucifera Sieb. et Zucc. It has significant neuroprotective activities against glutamate-induced toxicity in primary cultures of rat cortical cells. Synonyms: (3R,4R)-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-4-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one. Grade: 97.5%. CAS No. 149415-62-3. Molecular formula: C28H36O12. Mole weight: 564.59. | |
| Traxoprodil | Traxoprodil (CP101,606) is a potent and selective NMDA antagonist and protect hippocampal neurons with an IC50 of 10 nM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CP101,606. CAS No. 134234-12-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W018061. | |
| Trazodone | Trazodone (AF-1161 free base) is a triazolopyridine derivative that belongs to the class of serotonin receptor antagonists and reuptake inhibitors (SARIs). Trazodone has anti-depressant and anti-insomnious activity. Trazodone exerts antagonistic properties against a1- and a2-adrenergic receptors and histamine H1 receptors, with minimal anticholinergic effects[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AF-1161 free base. CAS No. 19794-93-5. Pack Sizes: 10 mM * 1 mL in DMSO; 25 mg; 50 mg; 100 mg. Product ID: HY-B0478A. | |
| Trazodone 1,4-Di-N-Oxide | A possible metabolite of Trazodone-HCl. Group: Biochemicals. Alternative Names: 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Trazodone BP Impurity B | Trazodone BP Impurity B. Uses: For analytical and research use. CAS No. 62337-66-0. Molecular formula: C19H23N5O. Mole weight: 337.43. Catalog: APB62337660. | |
| Trazodone BP Impurity C | Trazodone BP Impurity C. Uses: For analytical and research use. CAS No. 157072-19-0. Molecular formula: C19H22ClN5O. Mole weight: 371.87. Catalog: APB157072190. | |
| Trazodone BP Impurity E | Trazodone BP Impurity E. Uses: For analytical and research use. CAS No. 1346599-35-6. Molecular formula: C21H26ClN5O. Mole weight: 399.92. Catalog: APB1346599356. | |
| Trazodone BP Impurity F | Trazodone BP Impurity F. Uses: For analytical and research use. CAS No. 52605-52-4. Molecular formula: C13H19Cl3N2. Mole weight: 309.66. Catalog: APB52605524. | |
| Trazodone BP Impurity G | Trazodone BP Impurity G. Uses: For analytical and research use. CAS No. 2470436-00-9. Molecular formula: C17H27ClN2O. Mole weight: 310.87. Catalog: APB2470436009. | |
| Trazodone BP Impurity H | Trazodone BP Impurity H. Uses: For analytical and research use. CAS No. 6323-9-7. Molecular formula: C23H30Cl2N4. Mole weight: 433.42. Catalog: APB6323097. | |
| Trazodone BP Impurity I | Trazodone BP Impurity I. Uses: For analytical and research use. CAS No. 79975-63-6. Molecular formula: C16H16Cl2N2. Mole weight: 307.22. Catalog: APB79975636. | |
| Trazodone BP substance A | Trazodone BP substance A. Uses: For analytical and research use. CAS No. 55290-68-1. Molecular formula: C19H22ClN5O2. Mole weight: 387.87. Catalog: APB55290681. | |
| Trazodone BP substance C | Trazodone BP substance C. Uses: For analytical and research use. CAS No. 1263278-77-8. Molecular formula: C19H23Cl2N5O. Mole weight: 408.33. Catalog: APB1263278778. | |
| Trazodone BP substance D | Trazodone BP substance D. Uses: For analytical and research use. CAS No. 1263358-13-9. Molecular formula: C19H22BrN5O. Mole weight: 416.32. Catalog: APB1263358139. | |
| Trazodone-d6 (2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl-d6]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one) | Trazodone was originally discovered and developed in Italy in the 1960s by Angelini research laboratories as a second-generation antidepressant. It was developed according to the mental pain hypothesis, which was postulated from studying patients and which proposes that major depression is associated with a decreased pain threshold. Trazodone also has anxiolytic, and hypnotic effects (1). Trazodone was patented and marketed in many countries all over the world. It was approved by the Food and Drug Administration (FDA) at the end of 1981. Group: Biochemicals. Alternative Names: 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl-d6]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Trazodone-d6 hydrochloride | Trazodone-d6 (hydrochloride) is the deuterium labeled Trazodone hydrochloride[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AF-1161-d6. CAS No. 1181578-71-1. Pack Sizes: 1 mg; 5 mg. Product ID: HY-B0478AS. | |
| Trazodone-D6 hydrochloride solution | Trazodone-D6 hydrochloride solution. Uses: For analytical and research use. CAS No. 1181578-71-1. Mole weight: 414.36. EC Number: 200-659-6. Catalog: AP1181578711. | |
| Trazodone hydrochloride | Trazodone HCl is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders. Category: Active pharmaceutical ingredients. CAS No. 25332-39-2. Product ID: API25332392. Molecular formula: C19H23Cl2N5O. Mole weight: 408.325. Appearance: off-white powder. Standard: USP/EP. | |
| Trazodone Hydrochloride | Antidepressant. Group: Biochemicals. Alternative Names: 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one Hydrochloride; Bimaran; Desyrel; KB 831; Mesyrel; Molipaxin; Pragmazone; Thombran; Tombran; Trazodone hydrochloride; Trazolan; Trittico. Grades: Highly Purified. CAS No. 25332-39-2. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Trazodone hydrochloride EP Impurity G | Trazodone hydrochloride EP Impurity G. Uses: For analytical and research use. CAS No. 2512213-25-9. Molecular formula: C17H28Cl2N2O. Mole weight: 347.32. Catalog: APB2512213259. | |
| Trazodone Impurity 10 | Trazodone Impurity 10. Uses: For analytical and research use. CAS No. 2727463-29-6. Molecular formula: C40H46Cl2N10O2. Mole weight: 769.78. Catalog: APB2727463296. | |
| Trazodone impurity 1 (semicarbazide hydrochloride) | Trazodone impurity 1 (semicarbazide hydrochloride). Uses: For analytical and research use. CAS No. 563-41-7. Molecular formula: CH6ClN3O. Mole weight: 111.53. Catalog: APB563417. | |
| Trazodone impurity 2 | Trazodone impurity 2. Uses: For analytical and research use. CAS No. 1263358-12-8. Molecular formula: C19H21Cl2N5O. Mole weight: 406.31. Catalog: APB1263358128. | |
| Trazodone impurity 3 | Trazodone impurity 3. Uses: For analytical and research use. CAS No. 157072-18-9. Molecular formula: C19H22ClN5O. Mole weight: 371.87. Catalog: APB157072189. | |
| Trazodone Impurity 5 | Trazodone Impurity 5. Uses: For analytical and research use. CAS No. 32229-98-4. Molecular formula: C13H19ClN2O. Mole weight: 254.76. Catalog: APB32229984. | |
| Trazodone Impurity 6 | Trazodone Impurity 6. Uses: For analytical and research use. Molecular formula: C40H49Cl5N10O2. Mole weight: 879.15. Catalog: APB11651. | |
Our database is helping our users find suppliers everyday.
